Timothy Hutchings, DO
Obstetrics & Gynecology · Medford, ORNPI 1144345455
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.1%), education and consulting fees — rather than concentrated in one kind of arrangement. Coloplast accounts for 72.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $7,251 and has fallen 76.4% since, to $1,713 in 2025. Among obstetrics & gynecology clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 200 payments — averaging $114.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$17K
- Caldera Medical, Inc$4K
- Medtronic$1K
- Bluewind Medical$461
- Boston Scientific$167
- AbbVie$107
- plus $322 from 6 others
What the payments were for
- Consulting fees$5,22023%
- Travel & lodging$7203%
- Food & beverage$11,03248%
- Education$5,43124%
- Gifts$5122%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 116 | $16,700 |
| Caldera Medical, Inc | 38 | $4,022 |
| Medtronic(2 entities) | 18 | $1,135 |
| Bluewind Medical | 10 | $461 |
| Boston Scientific | 4 | $167 |
| AbbVie | 5 | $107 |
| Astellas Pharma US Inc | 2 | $100 |
| Axonics, Inc. | 2 | $92 |
| Coopersurgical, Inc. | 2 | $46 |
| Dysis Medical, Inc. | 1 | $35 |
| Johnson & Johnson | 1 | $31 |
| Intuitive Surgical | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,915 in reported general payments places this provider in the 95th percentile of 480 obstetrics & gynecology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 68 | $44,204 |
| PremarinEstrogens, Conjugated | 32 | $13,698 |
| Estradiol | 191 | $11,836 |
| MyrbetriqMirabegron | 19 | $11,364 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 76 | $5,331 |
| Trospium Chloride ErTrospium Chloride | 23 | $2,164 |
| Methenamine Hippurate | 18 | $1,075 |
| Tolterodine Tartrate ErTolterodine Tartrate | 26 | $803 |
| Trospium Chloride | 25 | $665 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 22 | $519 |
| NitrofurantoinNitrofurantoin Macrocrystal | 14 | $377 |
| Oxybutynin Chloride ErOxybutynin Chloride | 20 | $213 |
| Clobetasol Propionate | 13 | $147 |
| Mupirocin | 14 | $119 |
| CefuroximeCefuroxime Axetil | 24 | $119 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $100 | $11,36419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 480 obstetrics & gynecology providers in Oregon.
Other obstetrics & gynecology in Medford
- Julie KingMedford$17K
- Mary StrizziMedford$2K
- Audra Norris-JacobGresham$94K
- Amanda ClarkPortland$65K
- Robert HarderSalem$57K
- Brooke KyleSpringfield$55K
- Jeffrey JensenPortland$40K
- Lisa BayerPortland$23K
- Denis DaliskySilverton$22K
- Rachael SmithBend$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.